Biomarkers of Epithelial-Mesenchymal Transition in Squamous Cell Carcinoma (original) (raw)

Abstract

An understanding of the process by which tumor cells destroy the basement membrane of the surface epithelium, invade, and metastasize is essential to the development of novel treatment of head and neck squamous cell carcinoma (HNSCC). In recent years, there has been increased interest in the role of epithelial-mesenchymal transition (EMT) in invasion. EMT is a process that describes the development of motile, mesenchymal-like cells from non-motile parent epithelial cells. There are 3 known types of EMT that mediate development, wound healing, and carcinogenesis. This review summarizes studies of known EMT biomarkers in the context of HNSCC progression. The biomarkers discussed come from a wide range of proteins, including cell-surface proteins (E-cadherin, N-cadherin, and Integrins), cytoskeletal proteins (α-Smooth Muscle Actin, Vimentin, and β-catenin), extracellular matrix proteins (Collagens, Fibronectin, and Laminin), and transcription factors (SNAIL1, SNAIL2, TWIST, and LEF-1). Overall, the findings of these studies suggest that EMT mediates HNSCC progression. The mechanistic role of the EMT markers that have been associated with HNSCC should be more clearly defined if new anti-HNSCC therapies to block EMT progression are to be developed.

Get full access to this article

View all access and purchase options for this article.

References

Biddle A, Liang X, Gammon L, Fazil B, Harper LJ, Emich H, et al. (2011). Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. Cancer Res 71:5317-5326.

Calmon MF, Colombo J, Carvalho F, Souza FP, Filho JF, Fukuyama EE, et al. (2007). Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer. Cancer Genet Cytogenet 173:31-37.

Chang HW, Roh JL, Jeong EJ, Lee SW, Kim SW, Choi SH, et al. (2008). Wnt signaling controls radiosensitivity via cyclooxygenase-2-mediated Ku expression in head and neck cancer. Int J Cancer 122:100-107.

Chen C, Mendez E, Houck J, Fan W, Lohavanichbutr P, Doody D, et al. (2008). Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 17:2152-2162.

Chen C, Wei Y, Hummel M, Hoffmann TK, Gross M, Kaufmann AM, et al. (2011). Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One 6:e16466.

Dikshit RP, Gillio-Tos A, Brennan P, De Marco L, Fiano V, Martinez-Penuela JM, et al. (2007). Hypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and hypopharyngeal cancers. Cancer 110:1745-1751.

Dooley TP, Reddy SP, Wilborn TW, Davis RL (2003). Biomarkers of human cutaneous squamous cell carcinoma from tissues and cell lines identified by DNA microarrays and qRT-PCR. Biochem Biophys Res Commun 306:1026-1036.

Drake JM, Barnes JM, Madsen JM, Domann FE, Stipp CS, Henry MD (2010). ZEB1 coordinately regulates laminin-332 and {beta}4 integrin expression altering the invasive phenotype of prostate cancer cells. J Biol Chem 285:33940-33948.

Dyce OH, Ziober AF, Weber RS, Miyazaki K, Khariwala SS, Feldman M, et al. (2002). Integrins in head and neck squamous cell carcinoma invasion. Laryngoscope 112:2025-2032.

Egeblad M, Rasch MG, Weaver VM (2010). Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol 22:697-706.

Eriksen JG, Steiniche T, Overgaard J (2005). The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma. Acta Oncol 44:50-58.

Farina AK, Bong YS, Feltes CM, Byers SW (2009). Post-transcriptional regulation of cadherin-11 expression by GSK-3 and beta-catenin in prostate and breast cancer cells. PLoS One 4:e4797.

Foroni C, Broggini M, Generali D, Damia G (2012). Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Cancer Treat Rev 38:689-697.

Gemmill RM, Roche J, Potiron VA, Nasarre P, Mitas M, Coldren CD, et al. (2011). ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett 300:66-78.

Goto M, Mitra RS, Liu M, Lee J, Henson BS, Carey T, et al. (2010). Rap1 stabilizes beta-catenin and enhances beta-catenin-dependent transcription and invasion in squamous cell carcinoma of the head and neck. Clin Cancer Res 16:65-76.

Hatsell S, Rowlands T, Hiremath M, Cowin P (2003). Beta-catenin and Tcfs in mammary development and cancer. J Mammary Gland Biol Neoplasia 8:145-158.

Hayry V, Makinen LK, Atula T, Sariola H, Makitie A, Leivo I, et al. (2010). Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue. Br J Cancer 102:892-897.

Hirakawa H, Shibata K, Nakayama T (2009). Localization of cortactin is associated with colorectal cancer development. Int J Oncol 35:1271-1276.

Hsu DS, Lan HY, Huang CH, Tai SK, Chang SY, Tsai TL, et al. (2010). Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer. Clin Cancer Res 16:4561-4571.

Huang CH, Yang WH, Chang SY, Tai SK, Tzeng CH, Kao JY, et al. (2009). Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis. Neoplasia 11:1371-1382.

Huang DH, Su L, Peng XH, Zhang H, Khuri FR, Shin DM, et al. (2009). Quantum dot-based quantification revealed differences in subcellular localization of EGFR and E-cadherin between EGFR-TKI sensitive and insensitive cancer cells. Nanotechnology 20:225102.

Jouppila-Matto A, Narkio-Makela M, Soini Y, Pukkila M, Sironen R, Tuhkanen H, et al. (2011). Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression. BMC Cancer 11:350.

Kauppila S, Stenback F, Risteli J, Jukkola A, Risteli L (1998). Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J Pathol 186:262-268.

Koontongkaew S, Amornphimoltham P, Monthanpisut P, Saensuk T, Leelakriangsak M (2011). Fibroblasts and extracellular matrix differently modulate MMP activation by primary and metastatic head and neck cancer cells. Med Oncol 29:690-703.

Lee JM, Turini M, Botteman MF, Stephens JM, Pashos CL (2004). Economic burden of head and neck cancer. A literature review. Eur J Health Econ 5:70-80.

Leemans CR, Braakhuis BJ, Brakenhoff RH (2011). The molecular biology of head and neck cancer. Nat Rev Cancer 11:9-22.

Lim KP, Cirillo N, Hassona Y, Wei W, Thurlow JK, Cheong SC, et al. (2011). Fibroblast gene expression profile reflects the stage of tumour progression in oral squamous cell carcinoma. J Pathol 223:459-469.

Lyons JG, Patel V, Roue NC, Fok SY, Soon LL, Halliday GM, et al. (2008). Snail up-regulates proinflammatory mediators and inhibits differentiation in oral keratinocytes. Cancer Res 68:4525-4530.

Marinkovich MP (2007). Tumour microenvironment: laminin 332 in squamous-cell carcinoma. Nat Rev Cancer 7:370-380.

Mendelsohn AH, Lai CK, Shintaku IP, Fishbein MC, Brugman K, Elashoff DA, et al. (2012). Snail as a novel marker for regional metastasis in head and neck squamous cell carcinoma. Am J Otolaryngol 33:6-13.

Mendez E, Houck JR, Doody DR, Fan W, Lohavanichbutr P, Rue TC, et al. (2009). A genetic expression profile associated with oral cancer identifies a group of patients at high risk of poor survival. Clin Cancer Res 15:1353-1361.

Menzin J, Lines LM, Manning LN (2007). The economics of squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 15:68-73.

Mitra RS, Goto M, Lee JS, Maldonado D, Taylor JM, Pan Q, et al. (2008). Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma. Cancer Res 68:3959-3969.

Montserrat N, Gallardo A, Escuin D, Catasus L, Prat J, Gutierrez-Avigno FJ, et al. (2011). Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: a cooperative effort? Hum Pathol 42:103-110.

Nakahara S, Miyoshi E, Noda K, Ihara S, Gu J, Honke K, et al. (2003). Involvement of oligosaccharide changes in alpha5beta1 integrin in a cisplatin-resistant human squamous cell carcinoma cell line. Mol Cancer Ther 2:1207-1214.

Nemeth Z, Szasz AM, Somoracz A, Tatrai P, Nemeth J, Gyorffy H, et al. (2009). Zonula occludens-1, occludin, and E-cadherin protein expression in biliary tract cancers. Pathol Oncol Res 15:533-539.

Nguyen PT, Kudo Y, Yoshida M, Kamata N, Ogawa I, Takata T (2011). N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition. Histol Histopathol 26:147-156.

Ou DL, Chien HF, Chen CL, Lin TC, Lin LI (2008). Role of Twist in head and neck carcinoma with lymph node metastasis. Anticancer Res 28:1355-1359.

Paccione RJ, Miyazaki H, Patel V, Waseem A, Gutkind JS, Zehner ZE, et al. (2008). Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility. Mol Cancer Ther 7:2894-2903.

Peinado H, Moreno-Bueno G, Hardisson D, Perez-Gomez E, Santos V, Mendiola M, et al. (2008). Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas. Cancer Res 68:4541-4550.

Polette M, Mestdagt M, Bindels S, Nawrocki-Raby B, Hunziker W, Foidart JM, et al. (2007). Beta-catenin and ZO-1: shuttle molecules involved in tumor invasion-associated epithelial-mesenchymal transition processes. Cells Tissues Organs 185:61-65.

Prud’homme GJ (2012). Cancer stem cells and novel targets for antitumor strategies. Curr Pharm Des 18:2838-2849.

Qian F, Zhang ZC, Wu XF, Li YP, Xu Q (2005). Interaction between integrin alpha(5) and fibronectin is required for metastasis of B16F10 melanoma cells. Biochem Biophys Res Commun 333:1269-1275.

Rowe RG, Weiss SJ (2008). Breaching the basement membrane: who, when and how? Trends Cell Biol 18:560-574.

Schmidt M, Schler G, Gruensfelder P, Hoppe F (2006). Differential gene expression in a paclitaxel-resistant clone of a head and neck cancer cell line. Eur Arch Otorhinolaryngol 263:127-134.

Segrelles C, Moral M, Lara MF, Ruiz S, Santos M, Leis H, et al. (2006). Molecular determinants of Akt-induced keratinocyte transformation. Oncogene 25:1174-1185.

Siegel R, Ward E, Brawley O, Jemal A (2011). Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61:212-236.

Tapper J, Kettunen E, El-Rifai W, Seppala M, Andersson LC, Knuutila S (2001). Changes in gene expression during progression of ovarian carcinoma. Cancer Genet Cytogenet 128:1-6.

Tijink BM, Neri D, Leemans CR, Budde M, Dinkelborg LM, Stigter-van Walsum M, et al. (2006). Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature. J Nucl Med 47:1127-1135.

Tsai YP, Yang MH, Huang CH, Chang SY, Chen PM, Liu CJ, et al. (2009). Interaction between HSP60 and beta-catenin promotes metastasis. Carcinogenesis 30:1049-1057.

Van Tubergen E, Vander Broek R, Lee J, Wolf G, Carey T, Bradford C, et al. (2011). Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma. Cancer 117:2677-2689.

Warawdekar UM, Zingde SM, Iyer KS, Jagannath P, Mehta AR, Mehta NG (2006). Elevated levels and fragmented nature of cellular fibronectin in the plasma of gastrointestinal and head and neck cancer patients. Clin Chim Acta 372:83-93.

Wheelock MJ, Johnson KR (2003). Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 19:207-235.

Wu H, Lotan R, Menter D, Lippman SM, Xu XC (2000). Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomas. Anticancer Res 20:1385-1390.

Yang MH, Chang SY, Chiou SH, Liu CJ, Chi CW, Chen PM, et al. (2007). Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer. Oncogene 26:1459-1467.

Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY, Yang WH, et al. (2010). Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 12:982-992.

Yang Z, Zhang X, Gang H, Li X, Li Z, Wang T, et al. (2007). Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression. Biochem Biophys Res Commun 358:925-930.

Yoon Y, Liang Z, Zhang X, Choe M, Zhu A, Cho HT, et al. (2007). CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models. Cancer Res 67:7518-7524.

Zeisberg M, Neilson EG (2009). Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119:1429-1437.

Zhao Z, Ge J, Sun Y, Tian L, Lu J, Liu M, et al. (2012). Is E-cadherin immunoexpression a prognostic factor for head and neck squamous cell carcinoma (HNSCC)? A systematic review and meta-analysis. Oral Oncol 48:761-767.